A simplified echocardiographic technique for detecting continuous-flow left ventricular assist device malfunction due to pump thrombosis

被引:30
|
作者
Estep, Jerry D. [1 ]
Vivo, Rey P. [1 ,2 ]
Cordero-Reyes, Andrea M. [1 ]
Bhimaraj, Arvind [1 ]
Trachtenberg, Barry H. [1 ]
Torre-Amione, Guillermo [1 ,3 ]
Chang, Su Min [1 ]
Elias, Barbara [1 ]
Bruckner, Brian A. [1 ]
Suarez, Erik E. [1 ]
Loebe, Matthias [1 ]
机构
[1] Houston Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA
[2] Univ Calif Los Angeles, Ahmanson Cardiomyopathy Ctr, Mech & Circulatory Support & Heart Transplantat P, Los Angeles, CA USA
[3] Catedra Cardiol & Med Vasc Tecnol Monterrey, Monterrey, Nuevo Leon, Mexico
来源
关键词
heart failure; left ventricular assist device; thrombosis; echocardiography; cardiomyopathy; AMERICAN-SOCIETY; INTERNATIONAL SOCIETY; EUROPEAN-ASSOCIATION; STANDARDS COMMITTEE; HEART-FAILURE; TASK-FORCE; RECOMMENDATIONS; GUIDELINES; DIAGNOSIS; QUANTIFICATION;
D O I
10.1016/j.healun.2014.01.865
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Malfunction of a continuous-flow left ventricular assist device (CF-LVAD) due to device thrombosis is a potentially life-threatening event that currently presents a diagnostic challenge. We aimed to propose a practical echocardiographic assessment to diagnose LVAD malfunction secondary to pump thrombosis. METHODS: Among 52 patients implanted with a CF-LVAD from a single center who underwent echocardiographic pump speed-change testing, 12 had suspected pump thrombosis as determined by clinical, laboratory, and/or device parameters. Comprehensive echocardiographic evaluation was performed at baseline pump speed and at each 1,000-rpm interval from the low setting of 8,000 rpm to the high setting of 11,000 rpm in 11 of these patients. RESULTS: Receiver operating characteristic curves and stepwise logistic regression analyses showed that the best diagnostic parameters included changes in the LV end-diastolic diameter (<0.6 cm), aortic valve opening time (<80 msec), and deceleration time of mitral inflow (<70 msec) from lowest to highest pump speed. One parameter was predictive of pump malfunction, with 100% sensitivity and 89% specificity, whereas 2 of 3 parameters increased the sensitivity to 100% and specificity to 95%. CONCLUSIONS: The 3 echocardiographic variables of measured changes in LV end-diastolic diameter, aortic valve opening time, and deceleration time of mitral inflow between the lowest (8,000 rpm) and highest pump speed settings (11,000 rpm) during echo-guided pump speed-change testing appear highly accurate in diagnosing device malfunction in the setting of pump thrombosis among patients supported with CF-LVAD. Further investigation is warranted to create and validate a prediction score. (C) 2014 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:575 / 586
页数:12
相关论文
共 50 条
  • [41] Diagnosis and Management of Pump Thrombosis in Patients with Continuous-Flow Ventricular Assist Devices
    Ertugav, S.
    Engin, C.
    Daylan, A.
    Pektok, E.
    Ozturk, P.
    Nalbantgil, S.
    Yagdi, T.
    Ozbaran, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S238 - S239
  • [42] Is Resternotomy a Risk for Continuous-Flow Left Ventricular Assist Device Outcomes?
    Tsiouris, Athanasios
    Brewer, Robert J.
    Borgi, Jamil
    Hodari, Arielle
    Nemeh, Hassan W.
    Cogan, Chad M.
    Paone, Gaetano
    Morgan, Jeffrey A.
    JOURNAL OF CARDIAC SURGERY, 2013, 28 (01) : 82 - 87
  • [43] Complete coronary thrombolysis on continuous-flow left ventricular assist device
    Ichihara, Yuki
    Hamasaki, Azumi
    Saito, Satoshi
    Niinami, Hiroshi
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 60 (03) : 721 - 721
  • [44] Erythrocyte aging as a mechanism of anemia and a biomarker of device thrombosis in continuous-flow left ventricular assist devices
    Taimeh, Ziad
    Koene, Ryan J.
    Furne, Julie
    Singal, Ashish
    Eckman, Peter M.
    Levitt, Michael D.
    Pritzker, Marc R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (06): : 625 - 632
  • [45] Erythrocyte Aging as a Mechanism of Anemia and a Biomarker of Device Thrombosis in Continuous-Flow Left Ventricular Assist Devices
    Taimeh, Ziad
    Koene, Ryan
    Furne, Julie
    Singal, Ashish
    Eckman, Peter
    Levitt, Michael
    Pritzker, Marc
    CIRCULATION, 2016, 134
  • [46] Log files analysis and evaluation of circadian patterns for the early diagnosis of pump thrombosis with a centrifugal continuous-flow left ventricular assist device
    Consolo, Filippo
    Esposti, Federico
    Gustar, Adrian
    De Bonis, Michele
    Pappalardo, Federico
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (10): : 1077 - 1086
  • [47] Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate II
    S. Akin
    O.I. Soliman
    A.A. Constantinescu
    F. Akca
    O. Birim
    R.T. van Domburg
    O. Manintveld
    K. Caliskan
    Netherlands Heart Journal, 2016, 24 : 134 - 142
  • [48] Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate II
    Akin, S.
    Soliman, O. I.
    Constantinescu, A. A.
    Akca, F.
    Birim, O.
    van Domburg, R. T.
    Manintveld, O.
    Caliskan, K.
    NETHERLANDS HEART JOURNAL, 2016, 24 (02) : 134 - 142
  • [49] THE EFFECT OF PUMP OBSTRUCTIONS IN A CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE
    Martina, J. R.
    Rodermans, B. F. M.
    Sukkel, E.
    Pennings, K. A. M. A.
    Rutten, M.
    Lahpor, J. R.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2010, 33 (07): : 471 - 471
  • [50] Continuous-flow ventricular assist device - Reply
    Miller, Leslie W.
    Pagani, Francis D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (22): : 2305 - 2306